• Monday, September 20, 2021
India corona update 
Total Fatalities 349,186
Total Cases 28,909,975
Today's Fatalities 2,427
Today's Cases 100,636
India corona update 
Total Fatalities 349,186
Total Cases 28,909,975
Today's Fatalities 2,427
Today's Cases 100,636

HEALTH

Dr Reddy’s says trials of Russian Sputnik-V vaccine may end as early as March

(Photo by NATALIA KOLESNIKOVA/AFP via Getty Images)

By: ShelbinMS

Drugmaker Dr Reddy’s Laboratories Ltd on Wednesday rolled out a preliminary timeline for the India trials of Russia’s coronavirus vaccine candidate, with the late-stage expected to be completed by as early as March 2021.

Chief Executive Officer Erez Israeli said enrolment to the mid-stage trial of the Sputnik-V vaccine will start in the next few weeks and the trial was likely to end by December.

“(Phase 3 trial) can be over as fast as the end of March, but it could go into April or May,” Israeli said on a post-earnings press briefing, adding the timeline will depend on the Phase 2 trial results and further approvals from authorities.

With 8 million COVID-19 infections and second only to the United States, India is pinning its hopes on a vaccine to stem the spread of the pandemic.

The ongoing festive season and a state assembly election are seen by healthcare experts as adding to the challenges in containing the outbreak.

The Hyderabad-based company had received renewed approval for late-stage clinical trials in India of the Sputnik-V vaccine earlier this month, after initially signing a deal with the Russian Direct Investment Fund in September.

The company expects to enrol 100 participants for the mid-stage trial and 1,500 people for the late-stage.

The drugmaker, which last week isolated all its data centre services as a preventive measure following a cyberattack, said it was a ransomware attack, but was yet to ascertain if any personal information was accessed.

(Reuters)

Related Stories